MedTrace Logo

Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to Golimumab

NCT02414984 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2017-02-13

No results posted yet for this study

Summary

The purpose of this study is to describe adherence to golimumab in Colombian participants with rheumatoid arthritis (RA) experiencing adequate treatment response, in a real-world clinical settings.

Conditions

Interventions

BIOLOGICAL

Golimumab

This is an observational study. Participants with rheumatoid arthritis in Colombia will be observed for 24 months.

Sponsors & Collaborators

  • Janssen-Cilag, S.A.

    lead INDUSTRY

Principal Investigators

  • Janssen-Cilag, S.A. Clinical Trial · Janssen-Cilag, S.A.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02414984 on ClinicalTrials.gov